The DOI matches its Crossref record; the references it cites are not checked yet.
A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice
Open accessAbstract
Cell penetrating peptides (CPP) represent a novel approach to facilitate cytoplasmic delivery of macromolecules. The DNA binding domain of Drosophila Antennapedia contains 60 amino acids and consists of 3 α-helices, with internalizing activity mapped to a 16-amino acid peptide penetratin (Antp) within the third α-helix. Here, we report on the use of penetratin to deliver a multiple antigen peptide (MAP) incorporating the immunodominant CD8 epitope of ovalbumin, SIINFEKL (MAPOVACD8). We demonstrate that penetratin linked to the MAPOVACD8 construct either by a disulfide (SS) or thioether (SC) linkage promotes the uptake, cross presentation and subsequent in vivo proliferation and generation of OVACD8 (SIINFEKL)-specific T cells. The MAPOVACD8 construct without penetratin is not presented by MHC class I molecules nor does it generate an in vivo IFN-γ response in C57BL/6 mice. Moreover, we clearly define the uptake and intracellular processing pathways of AntpMAPOVACD8 SS and SC revealing the majority of AntpMAPOVACD8 is taken up by DC via an endocytic, proteasome and tapasin independent mechanism. We also show that the uptake mechanism of AntpMAPOVACD8 is dose dependent and uptake or intracellular processing is not altered by the type of chemical linkage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
References 30 · Cited by 24
Research works printed but not linked: 30
- Mittendorf, 2007, Breast cancer vaccines: promise for the future or pipe dream?, Cancer, 110, 1677, 10.1002/cncr.22978 · DOI
- Trombetta, 2005, Cell biology of antigen processing in vitro and in vivo, Ann. Rev. Immunol., 23, 975, 10.1146/annurev.immunol.22.012703.104538 · DOI
- Foerg, 2008, On the biomedical promise of cell penetrating peptides: limits versus prospects, J. Pharm. Sci., 97, 144, 10.1002/jps.21117 · DOI
- Yang, 2008, A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency, Mol. Immunol., 45, 1674, 10.1016/j.molimm.2007.10.026 · DOI
- Chikh, 2001, Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes, J. Immunol. Methods, 254, 119, 10.1016/S0022-1759(01)00411-2 · DOI
- Batchu, 2005, Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma, Cancer Res., 65, 10041, 10.1158/0008-5472.CAN-05-1383 · DOI
- Schutze-Redelmeier, 2004, Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes, Vaccine, 22, 1985, 10.1016/j.vaccine.2003.10.028 · DOI
- Hung, 2001, Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen, J. Immunol., 166, 5733, 10.4049/jimmunol.166.9.5733 · DOI
- Pouniotis, 2006, Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway, Immunology, 117, 329, 10.1111/j.1365-2567.2005.02304.x · DOI
- Zheng, 2005, Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle, J. Virol., 79, 1948, 10.1128/JVI.79.3.1948-1953.2005 · DOI
- Baz, 2008, Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses, Vaccine, 26, 2570, 10.1016/j.vaccine.2008.03.022 · DOI
- Justesen, 2007, Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A*0201 transgenic mice, Immunology, 122, 326, 10.1111/j.1365-2567.2007.02643.x · DOI
- Lu, 2004, Multiepitope trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses, J. Immunol., 172, 4575, 10.4049/jimmunol.172.7.4575 · DOI
- Dakappagari, 2005, Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T-cell responses in HLA-A*201 mice, J. Pept. Res., 65, 189, 10.1111/j.1399-3011.2005.00212.x · DOI
- Purcell, 2003, Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design, J. Pept. Sci., 9, 255, 10.1002/psc.456 · DOI
- Price, 2006, A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells, Exp. Neurol., 201, 193, 10.1016/j.expneurol.2006.03.030 · DOI
- Sanderson, 1994, LacZ inducible, antigen/MHC-specific T cell hybrids, Int. Immunol., 6, 10.1093/intimm/6.3.369 · DOI
- Duchardt, 2007, A comprehensive model for the cellular uptake of cationic cell-penetrating peptides, Traffic, 8, 848, 10.1111/j.1600-0854.2007.00572.x · DOI
- Jones, 2005, Characterisation of cell-penetrating peptide-mediated peptide delivery, Br. J. Pharmacol., 145, 1093, 10.1038/sj.bjp.0706279 · DOI
- Weidt, 1994, CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins, J. Immunol. (Baltimore, Md.: 1950), 153, 2554, 10.4049/jimmunol.153.6.2554 · DOI
- Apostolopoulos, 2006, Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses, Vaccine, 24, 3191, 10.1016/j.vaccine.2006.01.032 · DOI
- Shibagaki, 2002, Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity, J. Immunol.(Baltimore, Md.: 1950), 168, 2393, 10.4049/jimmunol.168.5.2393 · DOI
- Finn, 2003, Cancer vaccines: between the idea and reality, Nat. Immunol. Rev., 3, 630, 10.1038/nri1150 · DOI
- Sheng, 2006, Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells, Immunology, 118, 372, 10.1111/j.1365-2567.2006.02384.x · DOI
- Pietersz, 2001, A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway, Vaccine, 19, 1397, 10.1016/S0264-410X(00)00373-X · DOI
- Kent, 2009, Total chemical synthesis of proteins, Chem. Soc. Rev., 38, 338, 10.1039/B700141J · DOI
- Camarero, 2005, Synthesis of proteins by native chemical ligation using Fmoc-based chemistry, Protein Pept. Lett., 12, 723, 10.2174/0929866054864166 · DOI
- Fischer, 2004, A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides, J. Biol. Chem., 279, 12625, 10.1074/jbc.M311461200 · DOI
- Gruenberg, 2001, The endocytic pathway: a mosaic of domains, Nat. Rev. Mol. Cell Biol., 2, 721, 10.1038/35096054 · DOI
- Lu, 2001, TAP-independent presentation of CTL epitopes by Trojan antigens, J. Immunol. (Baltimore, Md.: 1950), 166, 7063, 10.4049/jimmunol.166.12.7063 · DOI
Metadata
- Authors
- Brooks, N. A., Pouniotis, D. S., Sheng, K.-C., Apostolopoulos, V., & Pietersz, G. A.
- Affiliations
- Burnet Institute (AU)
- RMIT University (AU)
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 1798
- Issue
- 12
- Pages
- 2286-2295
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W1972085403
- Cited by
- 24
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2019: 1 · 2018: 4 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 960 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Cancer Council Victoria
- National Health and Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- cell-penetrating peptides, penetratin, multiple antigen peptide, SIINFEKL, antigen delivery, dendritic cell uptake, cross-presentation, MHC class I antigen presentation, T cell proliferation, intracellular processing, endocytosis, proteasome, thioether linkage, disulfide bonds, IFN-gamma response
- MeSH terms
- Animals, Epitopes, Carrier Proteins, Dendritic Cells, Dose-Response Relationship, Drug, Dose-Response Relationship, Immunologic, Drosophila, Endocytosis, Interferon-gamma, Ovalbumin, T-Lymphocytes, Histocompatibility Antigens Class I, Protein Structure, Secondary, Antigen Presentation, Membrane Transport Proteins, Proteasome Endopeptidase Complex, Cell Proliferation, Mice, Cell-Penetrating Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review